~~<i id='8340003BCA'><strike id='8340003BCA'><tt id='8340003BCA'><pre id='8340003BCA'></pre></tt></strike></i>~~

Home» leisure time» hotspot

hotspot

author：Wikipedia 2025-08-04 05:20:14 Page View：5

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： UCB departs biotech trade group BIO
Next article： Affirmative action in medical school literally saved lives

explore

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Morgan Health, with ambitious aims, wants you to know it’s still here

AdobeSANFRANCISCO—Almostthreeyearsago,thecountry’sbiggestbankunveiledaloftyplantofixthehealthcareind

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Judge agrees to delay next hearing in Trump classified documents case

1:01FormerPresidentandRepublicanpresidentialcandidateDonaldTrumppreparestodeliverremarksataNevadaRep